260
Participants
Start Date
February 28, 2014
Primary Completion Date
May 31, 2017
Study Completion Date
January 31, 2018
Nitazoxanide
"Participants 1 to 3 years old: 5 mL oral suspension (100 mg NTZ) every 12 hours for 5 days.~Participants 4 to 11 years old: 10 mL oral suspension (200 mg NTZ) every 12 hours for 5 days.~Participants 12 years and older: two 300-mg NTZ tablets orally twice daily for 5 days."
Placebo
"Participants 1 to 3 years old: 5 mL placebo oral suspension every 12 hours for 5 days.~Participants 4 to 11 years old: 10 mL placebo oral suspension every 12 hours for 5 days.~Participants 12 years and older: two placebo tablets orally twice daily for 5 days."
Instituto Nacional de Ciencias medicas y Nutricion Salvador Zubiran, Tlalpan
Instituto Nacional de Enfermedades Respiratorias, Tlalpan
Hospital General Dr. Aurelio Valdivieso, Oaxaca City
Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí City
Instituto Nacional de Pediatria, Coyoacán
Hospital Infantil de Mexico Federico Gomez, Tamaulipas
Mexican Emerging Infectious Diseases Clinical Research Network
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH